SOMMER RAE WILD NURKIC M.D., M.P.H.
Prescription History 1205247913
Radiology - Radiation Oncology in Fargo, ND


Quality Rating: 78.86 out of 100 score

NPI Status: Active since May 15, 2014

Contact Information

820 4TH ST N
FARGO, ND
ZIP 58102
Phone: (701) 234-6161
Fax: (701) 234-7592

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SOMMER RAE WILD NURKIC M.D., M.P.H., an active Radiation Oncology specialist practicing in Fargo, ND. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 83 documented patient claims. Among these therapy options, the most frequently utilized medication is Dexamethasone, which accounts for 33 claims alone.

Medication Index

No matching medications currently found on file.

Dexamethasone

Generic Formulation: DexamethasoneSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 33
30-Day Fills 33.8
Days Supply 384
ND State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills38.7
Peer Average Days Supply451
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across ND. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $277.44 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.41

State Avg Cost Per Claim

$11.85

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anti-inflammatory 9-fluoro-glucocorticoid.

Therapeutic Applications

Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Lidocaine Hcl Viscous

Generic Formulation: Lidocaine HclSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 70
ND State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills16.9
Peer Average Days Supply125
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across ND. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $202.42 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.57

State Avg Cost Per Claim

$22.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used on the skin to stop itching and pain from certain skin conditions (such as scrapes, minor burns, eczema, insect bites) and to treat minor discomfort and itching caused by hemorrhoids and certain other problems of the genital/anal area (such as anal fissures, itching around the vagina/rectum). Some forms of this medication are also used to decrease discomfort or pain during certain medical procedures/exams (such as sigmoidoscopy, cystoscopy). Lidocaine is a local anesthetic that works by causing temporary numbness/loss of feeling in the skin and mucous membranes.

Lorazepam

Generic Formulation: LorazepamSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 25
30-Day Fills 25.0
Days Supply 226
ND State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills49.2
Peer Average Days Supply1,135
Conservative Utilization

This provider writes prescriptions for this formulation 45.7% less frequently than the standard regional baseline metric for practitioners inside ND. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $83.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$3.33

State Avg Cost Per Claim

$7.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Therapeutic Applications

This medication is used to treat serious seizures that do not stop (status epilepticus). It is also used before surgeries or procedures to cause drowsiness, decrease anxiety, and cause forgetfulness about the procedure or surgery. Lorazepam belongs to a class of medications called benzodiazepines, which produce a calming effect on the brain and nerves (central nervous system). It is thought to work by increasing the effect of a certain natural chemical (GABA) in the brain.

Oxycodone Hcl

Generic Formulation: Oxycodone HclSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 111
ND State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills35.1
Peer Average Days Supply483
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 64.7% less volume than the regional standard for practitioners inside ND. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $248.60 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.72

State Avg Cost Per Claim

$13.70

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic derivative of CODEINE.

Therapeutic Applications

This medication is used to help relieve moderate to severe pain. Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like SOMMER RAE WILD NURKIC M.D., M.P.H. provides transparency into local medical care patterns within Fargo, ND.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Radiation Oncology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.